A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Off-the-Shelf, Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Authors :: Robin J Nakkula
Bhavana Bhatnagar
Gregory K. Behbehani
James S. Blachly
Sumithira Vasu
Prashant Trikha
Nicole Szuminski
Lynn O'Donnell
Dean A. Lee
Source :: Transplantation and Cellular Therapy. 27:S339-S340
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
business.industry
Phases of clinical research
Myeloid leukemia
Cell Biology
Hematology
Internal medicine
Relapsed refractory
Molecular Medicine
Immunology and Allergy
Medicine
Off the shelf
business

Full Text Access

Tools